TENET HEALTHCARE CORPORATION

NYSE: THC (Tenet Healthcare Corporation)

Last update: 6 days ago, 7:33PM

194.25

1.25 (0.65%)

  • 1D 0.65%
  • 5D 0.69%
  • 1M -10.14%
  • 6M 17.66%
  • YTD 55.13%
  • 1Y 33.38%
  • 5Y 490.78%
Previous Close 193.00
Open 192.62
Volume 1,037,925
Avg. Volume (3M) 1,072,878
Market Cap 17,162,181,632
Price / Earnings (TTM) 13.21
Price / Earnings (Forward) 12.27
Price / Sales 0.850
Price / Book 4.20
52 Weeks Range
109.82 (-43%) — 217.43 (11%)
Earnings Date 28 Oct 2025
Profit Margin 7.18%
Operating Margin (TTM) 16.16%
Diluted EPS (TTM) 15.91
Quarterly Revenue Growth (YOY) 3.30%
Quarterly Earnings Growth (YOY) 11.20%
Total Debt/Equity (MRQ) 158.70%
Current Ratio (MRQ) 1.71
Operating Cash Flow (TTM) 2.46 B
Levered Free Cash Flow (TTM) 899.88 M
Return on Assets (TTM) 7.63%
Return on Equity (TTM) 29.65%

Market Trend

Short Term Medium Term
Industry Medical Care Facilities (US) Mixed Mixed
Medical Care Facilities (Global) Bullish Mixed
Stock Tenet Healthcare Corporation Bullish Bullish

AIStockmoo Score

0.8
Analyst Consensus 4.0
Insider Activity NA
Price Volatility -0.5
Technical Moving Averages 0.0
Technical Oscillators -0.5
Average 0.75

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
THC 17 B - 13.21 4.20
UHS 14 B 0.18% 10.71 2.06
FMS 14 B 5.34% 16.60 0.870
DVA 9 B - 12.41 21.63
HCA 117 B 0.28% 19.38 -
EHC 12 B 0.29% 21.93 4.80

Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 50 as of July 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Sector Healthcare
Industry Medical Care Facilities
Investment Style Mid Core
% Held by Insiders 0.73%
% Held by Institutions 98.94%
52 Weeks Range
109.82 (-43%) — 217.43 (11%)
Price Target Range
224.00 (15%) — 260.00 (33%)
High 260.00 (UBS, 33.85%) Buy
Median 239.00 (23.04%)
Low 224.00 (Goldman Sachs, 15.32%) Buy
Average 238.00 (22.52%)
Total 12 Buy
Avg. Price @ Call 200.94
Firm Date Target Price Call Price @ Call
Barclays 21 Nov 2025 240.00 (23.55%) Buy 191.96
18 Sep 2025 229.00 (17.89%) Buy 190.29
JP Morgan 13 Nov 2025 230.00 (18.40%) Buy 196.66
Wells Fargo 13 Nov 2025 252.00 (29.73%) Buy 196.66
07 Oct 2025 238.00 (22.52%) Buy 204.83
Truist Securities 03 Nov 2025 240.00 (23.55%) Buy 201.39
RBC Capital 30 Oct 2025 252.00 (29.73%) Buy 208.62
Cantor Fitzgerald 29 Oct 2025 245.00 (26.13%) Buy 209.14
07 Oct 2025 190.00 (-2.19%) Buy 204.83
Guggenheim 29 Oct 2025 238.00 (22.52%) Buy 209.14
UBS 29 Oct 2025 260.00 (33.85%) Buy 209.14
Mizuho 17 Oct 2025 225.00 (15.83%) Buy 200.00
Goldman Sachs 14 Oct 2025 224.00 (15.32%) Buy 196.33
Keybanc 08 Oct 2025 225.00 (15.83%) Buy 200.48
B of A Securities 10 Sep 2025 225.00 (15.83%) Buy 191.78
Show more

No data within this time range.

Ex Date Announcement Date Payment Date Details
13 Mar 2000 06 Mar 2000 24 Mar 2000 0.01 Cash

Annual Dividend Yield

Year Annual Dividend ($) Frequency/Year Yield %
2000 0.010 1 0.01

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria